KRAS mutation status in colorectal cancer to predict response to EGFR targeted therapies: the need for a more precise definition

por Rouleau, E, Spyratos, F, Dieumegard, B, Guinebretière, J M, Lidereau, R, Bièche, I
Publicado 2008

Extensive molecular screening for hereditary non-polyposis colorectal cancer

por Dieumegard, B, Grandjouan, S, Sabourin, J-C, Bihan, M-L Le, Lefrère, I, Bellefqih, Pignon, J-P, Rougier, P, Lasser, P, Bénard, J, Couturier, D, Bressac-de Paillerets, B
Publicado 2000